Lexeo expands Friedreich ataxia pipeline with Mantle deal
Acquisition adds new frataxin‑targeted modalities
Read More
Author: John Pinching
AC immune reports week-100 progress in VacSyn trial
Phase 2 data show strong safety and immunogenicity
Read More
Carvykti delivers five-year remissions in early myeloma
Half of patients remained progression-free without maintenance
Read More
Grünenthal expands pain portfolio across Asia-Pacific
Partnership brings key medicines to eight markets
Read More
Heparegenix completes first darizmetinib treatment in phase 1b
Company prepares seamless transition into phase 2a development
Read More
